{"id":"tobramycin-and-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Ocular irritation"},{"rate":null,"effect":"Conjunctival erythema"},{"rate":null,"effect":"Eye discomfort"},{"rate":null,"effect":"Lid edema"},{"rate":null,"effect":"Increased intraocular pressure (with prolonged use)"}]},"_chembl":{"chemblId":"CHEMBL1697787","moleculeType":"Small molecule","molecularWeight":"528.57"},"_dailymed":{"setId":"7ed85675-bc46-4dd6-bb8f-7e98c3eb84e2","title":"TOBRAMYCIN AND DEXAMETHASONE SUSPENSION/ DROPS [SPORTPHARM LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tobramycin is an aminoglycoside antibiotic that binds to bacterial ribosomes and prevents protein synthesis, effectively killing susceptible gram-negative and gram-positive bacteria. Dexamethasone is a potent corticosteroid that suppresses inflammatory and immune responses by inhibiting phospholipase A2 and reducing production of inflammatory mediators. Together, they provide both antimicrobial and anti-inflammatory effects for ocular infections.","oneSentence":"Tobramycin kills bacteria by inhibiting protein synthesis, while dexamethasone reduces inflammation and immune response in the eye.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:39:14.319Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial conjunctivitis"},{"name":"Bacterial keratitis"},{"name":"Ocular inflammation associated with bacterial infection"}]},"trialDetails":[{"nctId":"NCT07332936","phase":"NA","title":"Tobradex as Intracanal Medicament","status":"COMPLETED","sponsor":"Umm Al-Qura University","startDate":"2023-07-01","conditions":"Symptomatic Irreversible Pulpitis, Postoperative Endodontic Pain Following Emergency Root Canal Treatment","enrollment":43},{"nctId":"NCT02137161","phase":"PHASE4","title":"Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2013-11","conditions":"Cataract, Pseudoexfoliation Syndrome","enrollment":62},{"nctId":"NCT06404541","phase":"PHASE4","title":"A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-10","conditions":"Ocular Surface Disease, Dry Eye Syndromes","enrollment":60},{"nctId":"NCT02528123","phase":"NA","title":"VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia","status":"COMPLETED","sponsor":"London Vision Clinic","startDate":"2016-04","conditions":"Myopia, Refractive Errors","enrollment":114},{"nctId":"NCT06200727","phase":"NA","title":"Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases","status":"UNKNOWN","sponsor":"Lei Du","startDate":"2023-01-01","conditions":"Platelet-rich Fibrin, Macular Holes, Pterygium","enrollment":170},{"nctId":"NCT06175676","phase":"PHASE1","title":"Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis","status":"COMPLETED","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2021-12-03","conditions":"Dacryocystorhinostomy, Hydroxybutyl Chitosan, Fluorouracil","enrollment":90},{"nctId":"NCT02873806","phase":"PHASE4","title":"Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2013-03","conditions":"Open-angle Glaucoma","enrollment":53},{"nctId":"NCT05362253","phase":"NA","title":"Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial","status":"COMPLETED","sponsor":"Yifeng Yu","startDate":"2021-03-01","conditions":"Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation","enrollment":40},{"nctId":"NCT02958514","phase":"NA","title":"Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2016-11","conditions":"Dry Eye Syndrome","enrollment":20},{"nctId":"NCT05314673","phase":"PHASE4","title":"Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients","status":"COMPLETED","sponsor":"University Hospital Fattouma Bourguiba","startDate":"2019-01-01","conditions":"Pterygium","enrollment":60},{"nctId":"NCT04624035","phase":"NA","title":"Implantable Phakic Lens (IPCL) VS Implantable Collamer Lens","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-10-10","conditions":"Myopia","enrollment":60},{"nctId":"NCT04571788","phase":"","title":"Treating Rhegmatogenous Retinal Detachment by Foldable Capsular Buckle","status":"UNKNOWN","sponsor":"Aier School of Ophthalmology, Central South University","startDate":"2019-09-01","conditions":"Rhegmatogenous Retinal Detachment, Surgery","enrollment":150},{"nctId":"NCT03739528","phase":"PHASE3","title":"Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery","status":"COMPLETED","sponsor":"NTC srl","startDate":"2018-09-03","conditions":"Cataract","enrollment":808},{"nctId":"NCT04322500","phase":"NA","title":"Probiotics for Chalaziosis Treatment in Children","status":"COMPLETED","sponsor":"University of Molise","startDate":"2019-02-01","conditions":"Chalazion","enrollment":26},{"nctId":"NCT04342507","phase":"NA","title":"Probiotics for Treatment of Chalazion in Adults","status":"COMPLETED","sponsor":"University of Molise","startDate":"2019-02-01","conditions":"Chalazion","enrollment":20},{"nctId":"NCT04022811","phase":"PHASE4","title":"Effect of Bromfenac on Pain Related to Pterygium Surgery","status":"COMPLETED","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2016-10","conditions":"Pterygium, Pain","enrollment":60},{"nctId":"NCT03975374","phase":"EARLY_PHASE1","title":"To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension","status":"UNKNOWN","sponsor":"Sutphin Drugs","startDate":"2019-06-15","conditions":"Blepharo Conjunctivitis","enrollment":5000},{"nctId":"NCT01230593","phase":"NA","title":"Chalazion Conservative Treatment Trial","status":"COMPLETED","sponsor":"McMaster University","startDate":"2010-11","conditions":"Chalazion Unspecified Eye, Unspecified Eyelid, Chalazion Left Eye, Unspecified Eyelid, Chalazion Right Eye, Unspecified Eyelid","enrollment":150},{"nctId":"NCT02007174","phase":"","title":"Bevacizumab Injection for Recurrent Pterygium","status":"COMPLETED","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2012-03","conditions":"Recurrent Pterygium","enrollment":38},{"nctId":"NCT02817191","phase":"NA","title":"Effects of Holy-Comod and Tears Naturale Forte in Patients After Phaco+IOL","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-06","conditions":"Age-related Cataract","enrollment":80},{"nctId":"NCT02540785","phase":"NA","title":"Early Changes Between Lenticule Extraction and Small-Incision Lenticule Extraction","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-04","conditions":"Myopia, Astigmatism","enrollment":41},{"nctId":"NCT02551796","phase":"NA","title":"Early Changes Among FLEx, LASIK and FS-LASIK","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-09","conditions":"Myopia, Astigmatism","enrollment":75},{"nctId":"NCT02734459","phase":"PHASE3","title":"A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery","status":"COMPLETED","sponsor":"Semler Research Center Pvt. Ltd.","startDate":"2013-11","conditions":"Bilateral Cataract","enrollment":756},{"nctId":"NCT00083551","phase":"PHASE3","title":"UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"1998-08","conditions":"Multiple Myeloma","enrollment":668},{"nctId":"NCT01103401","phase":"NA","title":"Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Veroia General Hospital","startDate":"2009-10","conditions":"Cataract","enrollment":145},{"nctId":"NCT01102244","phase":"PHASE3","title":"A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-04","conditions":"Blepharitis","enrollment":122},{"nctId":"NCT00404937","phase":"PHASE3","title":"Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle","status":"WITHDRAWN","sponsor":"Alcon Research","startDate":"2006-12","conditions":"Post-surgical Inflammation","enrollment":""},{"nctId":"NCT00362895","phase":"PHASE3","title":"A Bioequivalence Study of Tobradex AF","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2006-04","conditions":"Cataract","enrollment":995},{"nctId":"NCT01028027","phase":"PHASE3","title":"Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2009-10","conditions":"Conjunctivitis, Keratitis, Blepharitis","enrollment":357},{"nctId":"NCT00447577","phase":"PHASE4","title":"Zylet vs TobraDex in Blepharokeratoconjunctivitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2007-01","conditions":"Blepharokeratoconjunctivitis","enrollment":276},{"nctId":"NCT00532961","phase":"PHASE4","title":"Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2005-02","conditions":"Inflammation","enrollment":310},{"nctId":"NCT01227915","phase":"PHASE3","title":"Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis","status":"UNKNOWN","sponsor":"Azidus Brasil","startDate":"2011-02","conditions":"Acute Bacterial Conjunctivitis","enrollment":70},{"nctId":"NCT00781300","phase":"PHASE4","title":"Intraocular Pressure With Loteprednol and Dexamethasone","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2006-03","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":35}],"_emaApprovals":[],"_faersSignals":[{"count":60,"reaction":"DRUG INEFFECTIVE"},{"count":58,"reaction":"OCULAR HYPERAEMIA"},{"count":56,"reaction":"EYE PAIN"},{"count":54,"reaction":"VISION BLURRED"},{"count":52,"reaction":"EYE IRRITATION"},{"count":51,"reaction":"HEADACHE"},{"count":43,"reaction":"OFF LABEL USE"},{"count":40,"reaction":"RASH"},{"count":38,"reaction":"DIARRHOEA"},{"count":36,"reaction":"FATIGUE"}],"_approvalHistory":[{"date":"20000627","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20000720","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20011127","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20010307","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20000821","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20230721","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20230721","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20081106","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"20020205","type":"SUPPL","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"19991027","type":"ORIG","sponsor":"BAUSCH AND LOMB","applicationNumber":"ANDA064134"},{"date":"19951101","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19951101","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19941027","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19911231","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20020816","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19930831","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20200424","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20010402","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19980804","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20000620","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19990428","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20021211","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19990817","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19970731","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19990205","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19960927","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19960318","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19950803","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20210514","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19911231","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20210514","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20010316","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20000218","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19980211","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20030623","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19880818","type":"ORIG","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20000204","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19970909","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20021204","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19990407","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19960927","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19990311","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"19960927","type":"SUPPL","sponsor":"SANDOZ","applicationNumber":"NDA050592"},{"date":"20220211","type":"ORIG","sponsor":"PADAGIS US","applicationNumber":"ANDA212715"}],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tobradex"],"phase":"marketed","status":"active","brandName":"Tobramycin and dexamethasone","genericName":"Tobramycin and dexamethasone","companyName":"Bausch & Lomb Incorporated","companyId":"bausch-lomb-incorporated","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tobramycin kills bacteria by inhibiting protein synthesis, while dexamethasone reduces inflammation and immune response in the eye. Used for Bacterial conjunctivitis, Bacterial keratitis, Ocular inflammation associated with bacterial infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}